Literature DB >> 34528186

Association of quantitative computed tomography ındices with lung function and extent of pulmonary fibrosis in patients with systemic sclerosis.

Duygu Temiz Karadag1, Ozgur Cakir2, Senar San3, Ayten Yazici3, Ercument Ciftci2, Ayse Cefle3.   

Abstract

OBJECTIVES: The aim was to investigate the discriminative value of a wide range of quantitative computed tomography (qCT) parameters in systemic sclerosis (SSc) patients with and without pulmonary fibrosis (PF) and their association with pulmonary function tests (PFTs) and visual fibrosis scores (VFS).
METHOD: Thoracic high-resolution computed tomography (HRCT) images of SSc patients with and without PF were analyzed with Vitrea® Advanced Visualization software. The mean lung attenuation (MLA), skewness, kurtosis, and threshold-based volumes [low-density volume (LDV), medium-density volume (MDV), and high-density volume (HDV)] derived from the attenuation histograms of the right and left lungs were evaluated separately. Visual scores were measured semi-quantitatively and the overall extent of pulmonary parenchymal abnormality was calculated.
RESULTS: Forty-one SSc patients with PF (85.4% female; mean age 50.4 ± 15.6 years) were compared with 94 without PF (88.3% female; mean age 50 ± 11.5 years). All qCT parameters were significantly different between those with and without PF (p < 0.05). Amongst the qCT measurements, R-MLA, L-MLA, R-MDV, L-MDV, and left total lung volume (L-TLV) correlated with all three of forced vital capacity, carbon monoxide diffusion capacity, and VFS, even after adjustment for sex and age (|r|> 0.300 and p < 0.05). R-MLA, L-MLA, R-HDV/TLV, and L-HDV/TLV exhibited diagnostic accuracy in discriminating patients with PF (AUC value > 0.7).
CONCLUSION: QCT parameters differentiated SSc patients with PF from the ones without and showed a good correlation with VFS. With the application of user-friendly and less operator-dependent software, qCT analysis may become an objective tool for analysis of PF in SSc, complementary to PFTs and VFS. Key Points • Quantitative computed tomography parameters can accurately and objectively differentiate between SSc patients with and without PF. • Furthermore, in SSc patients with fibrosis, a moderate to a high correlation was identified between many of the qCT parameters, PFT results, and VFS.
© 2021. International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  High-resolution computed tomography; Lung density; Pulmonary fibrosis; Systemic sclerosis

Mesh:

Year:  2021        PMID: 34528186     DOI: 10.1007/s10067-021-05918-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

1.  Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life.

Authors:  Gianna Camiciottoli; Ilaria Orlandi; Maurizio Bartolucci; Eleonora Meoni; Francesca Nacci; Stefano Diciotti; Chiara Barcaroli; Maria Letizia Conforti; Massimo Pistolesi; Marco Matucci-Cerinic; Mario Mascalchi
Journal:  Chest       Date:  2007-03       Impact factor: 9.410

2.  Interobserver variability in the CT assessment of honeycombing in the lungs.

Authors:  Takeyuki Watadani; Fumikazu Sakai; Takeshi Johkoh; Satoshi Noma; Masanori Akira; Kiminori Fujimoto; Alexander A Bankier; Kyung Soo Lee; Nestor L Müller; Jae-Woo Song; Jai-Soung Park; David A Lynch; David M Hansell; Martine Remy-Jardin; Tomás Franquet; Yukihiko Sugiyama
Journal:  Radiology       Date:  2012-12-06       Impact factor: 11.105

3.  A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients.

Authors:  H G Kim; D P Tashkin; P J Clements; G Li; M S Brown; R Elashoff; D W Gjertson; F Abtin; D A Lynch; D C Strollo; J G Goldin
Journal:  Clin Exp Rheumatol       Date:  2010-11-03       Impact factor: 4.473

4.  Mapping and predicting mortality from systemic sclerosis.

Authors:  Muriel Elhai; Christophe Meune; Marouane Boubaya; Jérôme Avouac; Eric Hachulla; Alexandra Balbir-Gurman; Gabriela Riemekasten; Paolo Airò; Beatriz Joven; Serena Vettori; Franco Cozzi; Susanne Ullman; László Czirják; Mohammed Tikly; Ulf Müller-Ladner; Paola Caramaschi; Oliver Distler; Florenzo Iannone; Lidia P Ananieva; Roger Hesselstrand; Radim Becvar; Armando Gabrielli; Nemanja Damjanov; Maria J Salvador; Valeria Riccieri; Carina Mihai; Gabriella Szücs; Ulrich A Walker; Nicolas Hunzelmann; Duska Martinovic; Vanessa Smith; Carolina de Souza Müller; Carlo Maurizio Montecucco; Daniela Opris; Francesca Ingegnoli; Panayiotis G Vlachoyiannopoulos; Bojana Stamenkovic; Edoardo Rosato; Stefan Heitmann; Jörg H W Distler; Thierry Zenone; Matthias Seidel; Alessandra Vacca; Ellen De Langhe; Srdan Novak; Maurizio Cutolo; Luc Mouthon; Jörg Henes; Carlo Chizzolini; Carlos Alberto von Mühlen; Kamal Solanki; Simona Rednic; Lisa Stamp; Branimir Anic; Vera Ortiz Santamaria; Maria De Santis; Sule Yavuz; Walter Alberto Sifuentes-Giraldo; Emmanuel Chatelus; Jiri Stork; Jacob van Laar; Esthela Loyo; Paloma García de la Peña Lefebvre; Kilian Eyerich; Vanesa Cosentino; Juan Jose Alegre-Sancho; Otylia Kowal-Bielecka; Grégoire Rey; Marco Matucci-Cerinic; Yannick Allanore
Journal:  Ann Rheum Dis       Date:  2017-08-23       Impact factor: 19.103

Review 5.  Systemic sclerosis.

Authors:  Christopher P Denton; Dinesh Khanna
Journal:  Lancet       Date:  2017-04-13       Impact factor: 79.321

6.  Interstitial lung disease in systemic sclerosis: a simple staging system.

Authors:  Nicole S L Goh; Sujal R Desai; Srihari Veeraraghavan; David M Hansell; Susan J Copley; Toby M Maher; Tamera J Corte; Clare R Sander; Jonathan Ratoff; Anand Devaraj; Gracijela Bozovic; Christopher P Denton; Carol M Black; Roland M du Bois; Athol U Wells
Journal:  Am J Respir Crit Care Med       Date:  2008-03-27       Impact factor: 21.405

7.  Progression parameters for emphysema: a clinical investigation.

Authors:  Jan Stolk; Hein Putter; Els M Bakker; Saher B Shaker; David G Parr; Eeva Piitulainen; Erich W Russi; Elzbieta Grebski; Asger Dirksen; Robert A Stockley; Johan H C Reiber; Berend C Stoel
Journal:  Respir Med       Date:  2007-07-20       Impact factor: 3.415

8.  Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT.

Authors:  Simon L F Walsh; Lucio Calandriello; Nicola Sverzellati; Athol U Wells; David M Hansell
Journal:  Thorax       Date:  2015-11-19       Impact factor: 9.139

9.  Clinical Characteristics of Systemic Sclerosis With Interstitial Lung Disease.

Authors:  Eunju Jung; Chang-Hee Suh; Hyoun-Ah Kim; Ju-Yang Jung
Journal:  Arch Rheumatol       Date:  2018-01-15       Impact factor: 1.472

10.  Performance of a new quantitative computed tomography index for interstitial lung disease assessment in systemic sclerosis.

Authors:  Marialuisa Bocchino; Dario Bruzzese; Michele D'Alto; Paola Argiento; Alessia Borgia; Annalisa Capaccio; Emanuele Romeo; Barbara Russo; Alessandro Sanduzzi; Tullio Valente; Nicola Sverzellati; Gaetano Rea; Serena Vettori
Journal:  Sci Rep       Date:  2019-07-01       Impact factor: 4.379

View more
  1 in total

Review 1.  Management of Connective Tissue Disease-related Interstitial Lung Disease.

Authors:  Sakir Ahmed; Rohini Handa
Journal:  Curr Pulmonol Rep       Date:  2022-05-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.